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ABSTRACT
The GPCRDB is a molecular class-speciﬁc informa-
tion system that collects, combines, validates and
disseminates heterogeneous data on G protein-
coupled receptors (GPCRs). The database stores
data on sequences, ligand binding constants and
mutations. The system also provides computation-
ally derived data such as sequence alignments,
homology models, and a series of query and
visualization tools. The GPCRDB is updated auto-
matically once every 4–5 months and is freely
accessible at http://www.gpcr.org/7tm/.
INTRODUCTION
G protein-coupled receptors (GPCRs) are a major target for the
pharmaceutical industry as is reflected by the fact that more
than 50% of all medicines available today act on a GPCR (1).
GPCRs consist of seven transmembrane helices that are
connected by loops. The N-terminal extremity is always
located extra-cellularly, while the C-terminus extends into the
cytoplasm. GPCRs are found in a diverse range of species
where they are involved in signalling from outside the cell to
inside the cell. Most GPCRs detect a ligand, that upon binding,
elicits a response that is felt by the heterotrimeric G protein at
the cytosolic side. This G protein in turn activates a second
messenger system by modulating the activity of enzymes such
as adenylyl cyclase or phospholipase C. Ligands for GPCRs
are heterogeneous molecules and include ions, hormones,
neurotransmitters, peptides and proteins. Stimuli such as light,
taste or odor can activate sensory GPCRs [see (2) for review].
In a related application, we have used the molecular class-
specific information system (MCSIS) technology to maintain
the NucleaRDB nuclear receptor information system (8). In
this current report, the authors explain how the MCSIS
technology is used to maintain the GPCRDB.
The GPCRDB is presently the only regularly updated GPCR
information system available on the World Wide Web
[WWW; see (3) for a list of GPCR-related websites]. Since
its introduction in late 1994, the GPCRDB has received
increasing attention from the scientific community.
DATA CONTENT
The GPCRDB contains sequences, mutation and ligand
binding data that are regularly imported from the original
sources [SWISS-PROT (4), EMBL (5), TinyGRAP (6)].
Recently, a significant amount of ligand binding data was
incorporated from Organon (7). Table 1 summarises statistics
about the data content of the GPCRDB.
PRIMARY DATA
Sequences are updated as described previously (8).
Structure data is only available for bovine rhodopsin (9). For
years, there was no high-resolution structure of a GPCR and
the structure of the bacteriorhodopsin was used as a reference.
Thus, many individuals within and outside industry have built
3D models of a variety of GPCRs. Some of these models were
deposited in the GPCRDB, in addition to the 3D models we
automatically built based on three different templates.
Mutation data is obtained from the manually curated
TinyGRAP (6) and is fully integrated throughout the
GPCRDB. We also provide point mutation data extracted
from online literature using an automated procedure (Horn and
Cohen, in preparation).
Ligand-binding data has been obtained from a collection by
P. Seeman (10) and from Organon (7). Information on agonists
and antagonists binding is very difficult to collect because of
the complexity of the nomenclature (antagonists to activators
and agonists to repressors tend to show similar effects in
assays, which leads to confusion when extracting information
from literature). We encourage academic and industrial
researchers to submit their ligand binding data to the
GPCRDB, in order to make this information searchable and
more accessible to the scientific community.
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COMPUTATIONALLY-DERIVED DATA
Multiple sequence alignments are performed with WHAT IF
(11) using an iterative sequence-based profile (12). The
multiple sequence alignments are provided in different formats
(HSSP, MSF). In all the alignments, the seven transmembrane
helices are annotated and numbered using a general numbering
scheme suggested by Oliveira et al. (1993).
cDNA-protein alignments and phylogenetic trees are gener-
ated as described previously (8).
Correlated Mutation Analysis (CMA) is used to identify
pairs of residues that remained conserved or mutated in tandem
during evolution. The rationale behind this analysis is that
when a mutation occurs at a functionally important site, the
protein either becomes non-functional or may acquire its
original or a different function due to a compensatory mutation
at another position. Residues detected by the CMA method are
often involved in intermolecular interactions [e.g. between
ligands and receptors; see (13–15) for an explanation of the
methods and examples of CMA application]. Residues
detected by the CMA method are indicated in multiple
sequence alignments and in snake-like diagrams.
DATABASE CROSS-LINKING
For each GPCR, a table of cross-references lists all the
available pointers to local and remote information. This is done
automatically by reading the SWISS-PROT entries and
querying other remote resources and the GPCRDB itself. In
addition, we are currently trying to map the GPCR classifica-
tions in the GPCRDB to Gene Ontology (16) identifiers. The
Gene Ontology consortium provides a controlled vocabulary
for the description of molecular function, biological process
and cellular components of gene products. As a first step into
this direction, each table now contains a link to the
Gene Ontology database via the QuickGO system (http://
golgi.ebi.ac.uk/ego/index.html). In addition, we will integrate
the IUPHAR receptor codes, which will be publicly available
in December 2002.
DISSEMINATION FACILITIES
MCSIS provide fast and easy access to all information related
to an underlying molecular class. For this purpose we have
implemented and will continue to develop the four basic
information system tools: browsing, retrieval, query and
inferring. Inference engine facilities are as described pre-
viously (8).
Browsing. The data organisation is based on the pharmacolo-
gical classification of GPCRs and the main way to access the
data is via a hierarchical list of known families in agreement
with this classification. For a specific family, users can access
individual sequences, multiple sequence alignments, the pro-
files used to perform the latter, snake-like diagrams and phylo-
genetic trees. Each type of data is displayed in a WWW page
with hyperlinks to other data, where appropriate. Another way
to access the data is to browse lists that display one type of data
(e.g. all chromosomal locations, all mutations, etc). In addi-
tion, a dynamic page lists all SWISS-PROT and TrEMBL
entries present in the database. Two-dimensional snake-like
diagrams are used to represent and combine GPCR sequence,
2D structure and mutation information. These diagrams are
automatically generated using the Viseur program (17).
There are three types of snake-like diagrams: the first one dis-
plays mutation data for each receptor, the second superimposes
all the mutation data available for one receptor family onto the
corresponding consensus sequence and the last one shows the
residues detected by the CMA method for each receptor family.
In the first two types of diagrams, the ‘mutated’ residues are
hyperlinked to the TinyGRAP database (6). In the CMA
snake-like diagram, residues with a predicted important func-
tional role are hyperlinked to the multiple sequence alignments
and to details of the CMA results.
Retrieval. Most data can be retrieved in its native form using
the ‘save as’ option of the browser or via anonymous FTP from
ftp://www.gpcr.org.7tm/. A complete copy of the GPCRDB
can be made available to academic and industrial researchers
upon request (G.V.).
Query. A basic query system is also available to retrieve
GPCR entries using keywords and SWISS-PROT identifiers.
In addition, users can also run a BLAST search against the
GPCRDB sequence data via the CMBI server.
Inferences. CMA is a powerful tool for the computational
discovery of novel inter-residue relationships, and thus repre-
sent a useful inference engine. With little computational effort,
the potential functionally or structurally relevant residues are
selected from among the thousands of residues in each align-
ment. We make these residue positions available for browsing
purposes by mapping them onto multiple sequence alignments.
DISCUSSION
The GPCRDB started in 1993 as an Email-based system and
was converted in 1994 to the WWW. It has been in continuous
service now for almost 10 years and is probably the only non-
government sponsored database/information system with such
longevity. It is routinely used from fifty to a hundred thousand
times per month by researchers in industry and academia from
more than 120 countries (see the usage statistics at http://
www.gpcr.org/7tm/htmls/analog.html).
Table 1. Statistics about the September 2002 release of the GPCRDB
GPCR sequences 4609
Including fragments 1654
cDNA/protein pairwise alignments 3978
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3D Models (11 depositors) 1898
PDB files (links to) 78
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Although users are not obliged to inform us why they use the
GPCRDB, we have reason to believe that the main usage is
simple to retrieve information that would otherwise have to be
collected from multiple sites. Furthermore, the system is often
used to obtain knowledge about orphan receptors. Correlated
mutations, the GPCR specific BLAST, multiple sequence
alignments and phylogenetic trees are used for this purpose.
The existence of the GPCRDB as a recognizable site for
GPCR-related data also leads to the increased dissemination of
data. As an example, we received two large batches of ligand
binding data (7,10).
The so-called snake-like diagrams are a popular way to
access mutation data (Fig. 1). Some of the snake-like diagrams
have been used more than ten thousand times for this purpose.
The most important reason for the popularity of the
GPCRDB is probably its long term presence as a regularly
updated one-stop-resource for GPCR data.
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